Novo Nordisk A/S – Share repurchase programme

Bagsværd, Denmark, 1 July 2019 – On 7 May 2019, Novo Nordisk initiated a share repurchase programme in accordance with Article 5 of Regulation No 596/2014 of the European Parliament and Council of 16 April 2014 (MAR) and the Commission Delegated Regulation (EU) 2016/1052 of 8 March 2016 (the "Safe Harbour Rules"). This programme is part of the overall share repurchase programme of up to DKK 15 billion to be executed during a 12-month period beginning 1 February 2019.

Under the programme initiated 7 May 2019, Novo Nordisk will repurchase B shares for an amount up to DKK 2.7 billion in the period from 8 May 2019 to 7 August 2019.

Since the announcement as of 24 June 2019, the following transactions have been made under the programme:

 Number of
B shares
purchase price
value, DKK
Accumulated, last announcement3,843,000 1,255,256,544
24 June 2019125,000332.9441,617,055
25 June 2019125,000334.9241,865,163
26 June 2019125,000336.7242,089,417
27 June 2019125,000333.2241,652,206
28 June 2019125,000334.5241,815,478
Accumulated under the programme4,468,000 1,464,295,863

The details for each transaction made under the share repurchase programme are published on

With the transactions stated above, Novo Nordisk owns a total of 26,811,143 B shares of DKK 0.20, corresponding to 1.1% of the share capital, as treasury shares. The total amount of A and B shares in the company is 2,400,000,000 including treasury shares.

Novo Nordisk expects to repurchase B shares for an amount up to DKK 15 billion during a 12-month period beginning 1 February 2019. As of 28 June 2019, Novo Nordisk has since 1 February 2019 repurchased a total of 19,644,504 B shares at an average share price of DKK 325.75 per B share equal to a transaction value of DKK 6,399,249,464.

Further information

Anne Margrethe Hauge+45 4442
Ken Inchausti (US)+1 609 240
Peter Hugreffe Ankersen+45 3075
Valdemar Borum Svarrer+45 3079
Ann Søndermølle Rendbæk+45 3075
Kristoffer Due Berg (US)+1 609 235

Company announcement No 39/2019